medigraphic.com
Boletín Médico del Hospital Infantil de México

2011, Number 2

<< Back Next >>

Bol Med Hosp Infant Mex 2011; 68 (2)

Cysticercosis: neglected disease

Flisser A

Language: Spanish
References: 14
Page: 138-145
PDF size: 688.66 Kb.


ABSTRACT

Human neurocysticercosis is a disease associated with underdevelopment and occurs in countries with poor health infrastructure and poor health education.
Despite the fact that human cysticercosis is considered a neglected disease, in this paper the events that have facilitated its control in Mexico are described. Therefore, it can be considered that neurocysticercosis may no longer be a public health problem in our country.


REFERENCES

  1. Tropical Diseases Research. Research on neglected priority needs. Disponible en: http://apps.who.int/tdr/svc/research.

  2. Engels D, Urbani C, Belotto A, Meslin F, Savioli L. The control of human (neuro)cysticercosis: which way forward? Acta Trop 2003;87:177-182.

  3. Román G, Sotelo J, Del Brutto O, Flisser A, Dumas M, Wadia N, et al. A proposal to declare neurocysticercosis an international reportable disease. Bull WHO 2000;78:399-406.

  4. World Health Organization. Control of neurocysticercosis. Report of the Secretariat. Fifty-sixth World Health Assembly. Document A56/10. Geneva: World Health Organization, 2003. Disponible en: http://apps.who.int/gb/archive/pdf_files/WHA56/ea5610.pdf

  5. World Health Organization. Reunión de expertos de la Organización Mundial de la Salud en infecciones transmitidas por alimentos debidas a tremátodos y a teniasis/cisticercosis. Vientiane, República Democrática de la Gente de Laos; octubre 2009.

  6. Flisser A. Cisticercosis y teniosis. En: Flisser A, Pérez Tamayo R, eds. Aprendizaje de la Parasitología Basado en Oroblemas. México, D.F.: Editores de Textos Mexicanos (ETM); 2006. pp. 337-353.

  7. Flisser A, Correa D, Avila G, Maravilla P. Biology of Taenia solium, Taenia saginata and Taenia saginata asiatica. En: Murrell KD, ed. Manual on Taeniasis and Cysticercosis in Man and Animals: Detection, Treatment and Prevention. WHO/FAO (OIE); 2005. pp. 1-9.

  8. Mahanty S, Garcia HH. Cysticercosis Working Group in Perú. Cysticercosis and neurocysticercosis as pathogens affecting the nervous system. Prog Neurobiol 2010;91:172-184.

  9. Flisser A. Epidemiological studies of taeniasis and cysticercosis in Latin America. En: Craig P, Pawlowski Z, eds. Cestode Zoonoses: Echinococcosis and Cysticercosis, An Emergent and Global Problem. Amsterdam: IOS Press, NATO Science Series Vol. 341, 2002; pp. 3-11.

  10. Flisser A. Risk factors and control measures for taeniosis/cysticercosis. En: Craig P, Pawlowski Z, eds. Cestode Zoonoses: Echinococcosis and Cysticercosis, An Emergent and Global Problem. Amsterdam: IOS Press, NATO Science Series Vol. 341, 2002; pp. 335-342.

  11. Sorvillo F, Wilkins P, Shafir S, Eberhard M. Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis 2011;17:1-6.

  12. TDR for research on diseases of poverty, UNICEF-UNDPWorld Bank-WHO. Joint Coordinating Board Session 25, 2002. Disponible en: http//apps.who.int/tdr/svc/about/governance/jcb/jcb-session-25

  13. Flisser A, Correa D. Neurocysticercosis may no longer be a public health problem in Mexico. PLoS Negl Trop Dis 2010;4:e831.

  14. Secretaría de Salud. Modificación a la Norma Oficial Mexicana NOM-021-SSA2-1994, para la prevención y control del complejo teniosis/cisticercosis en el primer nivel de atención médica. México: Diario Oficial de la Federación; 2004. Disponible en: http://www.salud.gob.mx/unidades/cdi/nom/m021ssa294.html




2020     |     www.medigraphic.com